DLBCL radiotherapy offers strong consolidation after R-CHOP, though experts outline specific limitations for advanced-stage patients in clinical reviews.
Pharmacy oncology is reshaping cancer care as Minnesota leaders tackle operational and financial hurdles to expand outpatient bispecific antibody and CAR T‑cell